122 - The First Rule of Journal Club is That We Don’t Talk About Journal Club
In this episode, we discuss how to excel in your next journal club presentation or discussion...
36:50
122 - The First Rule of Journal Club is That We Don’t Talk About Journal Club
In this episode, we discuss how to excel in your next journal club presentation or discussion...
36:50
121 - But Wait, There’s More! Unusual Warfarin Interactions
In this episode, we will discuss some of the interesting and unusual warfarin interactions such...
51:31
120 - When it Rains it Pours: A Succinct Clinical Review of Hyponatremia due to SIADH
In this episode, we discuss the pathophysiology, drug-related causes, diagnosis, and treatment of...
41:08
119 - What Is the Buzz about Bempedoic Acid for Dyslipidemia?
In this episode, we discuss the latest dyslipidemia treatment agent bempedoic acid and dive into...
47:16
118 - Cocaine and Beta-blockers: Absolute Contraindication or Medical Myth?
In this episode, we discuss the proposed risks of using beta blockers in patients with cocaine...
34:11
117 - The Yin and Yang of ACEi/ARBs:How Do They Help and Harm Kidneys?
In this episode, we dive into the pharmacology of ACE inhibitors and ARBs, particularly...
40:05
116 - Taking Your Patient Counseling Skills to the Next Level: Clinical Pearls and Pitfalls to Avoid
In this episode, we partner with Dr. Danielle Candelario and Dr. Sneha Srivastava, clinical...
37:46
115 - What Every Pharmacist Should Know to Conquer Staph Aureus Infections
In this episode, we discuss the historical significance of Staphylococcus aureus including its...
40:30
In this episode, we discuss important nutritional deficiencies as well as pharmacologic changes...
42:53
113 - The Top 10 Clinical Pearls for Total Parenteral Nutrition (TPN)
In this episode, we review ten clinical pearls about total parenteral nutrition (TPN) that all...
31:40
112 - Fishing for Benefits - The Evidence for ASCVD Risk Reduction for Fish Oils
In this episode, we will discuss the most recent evidence for the use of omega-3 fatty acids...
42:11
111 - The Basics of Immune Checkpoint Inhibitors for Non-Oncology Healthcare Providers
In this episode, we chat with Eris Tollkuci, PharmD, BCOP regarding what every non-onc healthcare...
35:42
110 - Top 10 Updated Recommendations from the ADA Standards of Care 2020
In this episode, we summarize some of the most significant changes in the newest version of...
39:12
109 - Clinical Controversy: Can Obese Patients Take DOACs for Acute VTE?
In this episode, we review the pros, cons, and literature regarding the use of DOACs versus...
26:22
108 - 6 Reasons to be Addicted to Lifestyle Medicine
In this episode, we provide an overview of lifestyle medicine, its six pillars, and how it plays...
36:17
107 - You’re Going to Go Bananas Over this Brief Review of Hyperkalemia
In this episode, we discuss clinical pearls and management related to chronic and acute...
41:45
106 - It’s Finally Here! The 2019 IDSA CAP Guidelines
In this episode, we discuss the important updates in the 2019 IDSA Community Acquired Pneumonia...
38:45
105 - Unraveling the Mystery of P2Y12 Inhibitors: Clinical Pearls and Comparative Evidence
In this episode, we review the three oral P2Y12 inhibitors on the market (clopidogrel, prasugrel,...
37:28
104 - Breathtaking Updates from Global INitiative for Asthma (GINA) Guidelines 2019
In this episode, we will discuss what is the latest and greatest from the GINA (Global INitiative...
35:22
103 - How Can Peeing Sugar Improve Heart Failure? No One Knows, but We Know It Works!
In this episode, we discuss the newly published DAPA-HF trial, which studied dapagliflozin (a...
32:14